Clinical Medicine
Listando 20 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions
759
Twitter
1
Wikipedia
194
News
2
Policy
Article
Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
Antonia, S. J.; Villegas, A.; Daniel, D.; Vicente, D.; Murakami, S.; Hui, R.; Yokoi, T.; Chiappori, A.; Lee, K. H.; de Wit, M.; Cho, B. C.; Bourhaba, M.; Quantin, X.; Tokito, T.; Mekhail, T.; Planchard, D.; Kim, Y. -C.; Karapetis, C. S.; Hiret, S.; Ostoros
NEW ENGLAND JOURNAL OF MEDICINE
0028-4793 (2017)
DOI /
10.1056/nejmoa1709937
Green published
Mentions
303
Twitter
2
Wikipedia
45
News
4
Policy
Article
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
Socinski, M. A.; Jotte, R. M.; Cappuzzo, F.; Orlandi, F.; Stroyakovskiy, D.; Nogami, N.; Rodriguez-Abreu, D.; Moro-Sibilot, D.; Thomas, C. A.; Barlesi, F.; Finley, G.; Kelsch, C.; Lee, A.; Coleman, S.; Deng, Y.; Shen, Y.; Kowanetz, M.; Lopez-Chavez, A.; Sa
NEW ENGLAND JOURNAL OF MEDICINE
0028-4793 (2018)
DOI /
10.1056/nejmoa1716948
Mentions
396
Twitter
0
Wikipedia
17
News
0
Policy
Article
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
Provencio, Mariano; Nadal, Ernest; Insa, Amelia; Rosario Garcia-Campelo, Maria; Casal-Rubio, Joaquin; Domine, Manuel; Majem, Margarita; Rodriguez-Abreu, Delvys; Martinez-Marti, Alex; De Castro Carpeno, Javier; Cobo, Manuel; Lopez Vivanco, Guillermo; del Ba
LANCET ONCOLOGY
1470-2045 (2020)
DOI /
10.1016/s1470-2045(20)30453-8
Mentions
97
Twitter
0
Wikipedia
5
News
0
Policy
Article
Five-Year Outcomes From the Randomized, Phase III Trials CheckMate 017 and 057: Nivolumab Versus Docetaxel in Previously Treated Non-Small-Cell Lung Cancer
Borghaei, Hossein; Gettinger, Scott; Vokes, Everett E.; Chow, Laura Q. M.; Burgio, Marco Angelo; Carpeno, Javier de Castro; Pluzanski, Adam; Arrieta, Oscar; Frontera, Osvaldo Aren; Chiari, Rita; Butts, Charles; Wojcik-Tomaszewska, Joanna; Coudert, Bruno; G
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2021)
DOI /
10.1200/jco.20.01605
Gold other
Mentions
76
Twitter
0
Wikipedia
4
News
2
Policy
Article
Four-year survival with nivolumab in patients with previously treated advanced non-small-cell lung cancer: a pooled analysis
Antonia, Scott J.; Borghaei, Hossein; Ramalingam, Suresh S.; Horn, Leora; De Castro Carpeno, Javier; Pluzanski, Adam; Burgio, Marco A.; Garassino, Marina; Chow, Laura Q. M.; Gettinger, Scott; Crino, Lucio; Planchard, David; Butts, Charles; Drilon, Alexande
LANCET ONCOLOGY
1470-2045 (2019)
DOI /
10.1016/s1470-2045(19)30407-3
Green accepted
Mentions
76
Twitter
0
Wikipedia
4
News
0
Policy
Article
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
Liu, Stephen, V; Reck, Martin; Mansfield, Aaron S.; Mok, Tony; Scherpereel, Arnaud; Reinmuth, Niels; Garassino, Marina Chiara; Carpeno, Javier de Castro; Califano, Raffaele; Nishio, Makoto; Orlandi, Francisco; Alatorre-Alexander, Jorge; Leal, Ticiana; Chen
JOURNAL OF CLINICAL ONCOLOGY
0732-183X (2021)
DOI /
10.1200/jco.20.01055
Gold other
Mentions
68
Twitter
0
Wikipedia
2
News
0
Policy
Article
Safety and Efficacy of Bevacizumab Plus Standard-of-Care Treatment Beyond Disease Progression in Patients With Advanced Non-Small Cell Lung Cancer The AvaALL Randomized Clinical Trial
Gridelli, Cesare; De Castro Carpeno, Javier; Dingemans, Anne-Marie C.; Griesinger, Frank; Grossi, Francesco; Langer, Corey; Ohe, Yuichiro; Syrigos, Konstantinos; Thatcher, Nick; Das-Gupta, Ashis; Truman, Matt; Donica, Margarita; Smoljanovic, Vlatka; Bennou
JAMA ONCOLOGY
2374-2437 (2018)
DOI /
10.1001/jamaoncol.2018.3486
Green published, Bronze
Mentions
82
Twitter
0
Wikipedia
1
News
0
Policy
Article
Pretreatment Tissue TCR Repertoire Evenness Is Associated with Complete Pathologic Response in Patients with NSCLC Receiving Neoadjuvant Chemoimmunotherapy
Casarrubios, Marta; Cruz-Bermudez, Alberto; Nadal, Ernest; Insa, Amelia; Garcia Campelo, Maria del Rosario; Lazaro, Martin; Domine, Manuel; Majem, Margarita; Rodriguez-Abreu, Delvys; Martinez-Marti, Alex; de Castro-Carpeno, Javier; Cobo, Manuel; Lopez-Viva
CLINICAL CANCER RESEARCH
1078-0432 (2021)
DOI /
10.1158/1078-0432.ccr-21-1200
Mentions
63
Twitter
0
Wikipedia
0
News
0
Policy
Article
Blood biomarkers associated to complete pathological response on NSCLC patients treated with neoadjuvant chemoimmunotherapy included in NADIM clinical trial
Laza-Briviesca, Raquel; Cruz-Bermudez, Alberto; Nadal, Ernest; Insa, Amelia; Garcia-Campelo, Maria del Rosario; Huidobro, Gerardo; Domine, Manuel; Majem, Margarita; Rodriguez-Abreu, Delvys; Martinez-Marti, Alex; De Castro Carpeno, Javier; Cobo, Manuel; Lop
CLINICAL AND TRANSLATIONAL MEDICINE
2001-1326 (2021)
DOI /
10.1002/ctm2.491
Green published, Gold
Mentions
38
Twitter
0
Wikipedia
1
News
0
Policy
Article
SEOM clinical guidelines for the treatment of malignant pleural mesothelioma (2020)
Nadal, E.; Bosch-Barrera, J.; Cedres, S.; Coves, J.; Garcia-Campelo, R.; Guirado, M.; Lopez-Castro, R.; Ortega, A. L.; Vicente, D.; de Castro-Carpeno, J.
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2021)
DOI /
10.1007/s12094-020-02532-2
Green published
Mentions
51
Twitter
0
Wikipedia
0
News
0
Policy
Article
Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial
Sierra-Rodero, Belen; Cruz-Bermudez, Alberto; Nadal, Ernest; Garitaonaindia, Yago; Insa, Amelia; Mosquera, Joaquin; Casal-Rubio, Joaquin; Domine, Manuel; Majem, Margarita; Rodriguez-Abreu, Delvys; Martinez-Marti, Alex; De Castro Carpeno, Javier; Cobo, Manu
JOURNAL FOR IMMUNOTHERAPY OF CANCER
(2021)
DOI /
10.1136/jitc-2021-002804
Mentions
16
Twitter
0
Wikipedia
0
News
0
Policy
Article
Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience
Gutierrez-Sainz, L.; Martinez-Marin, V.; Vinal, D.; Martinez-Perez, D.; Pedregosa, J.; Garcia-Cuesta, J. A.; Villamayor, J.; Zamora, P.; Pinto, A.; Redondo, A.; Castelo, B.; Cruz, P.; Higuera, O.; Custodio, A.; Gallego, A.; Sanchez-Cabrero, D.; De Castro-C
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2020)
DOI /
10.1007/s12094-020-02515-3
Mentions
16
Twitter
0
Wikipedia
0
News
0
Policy
Article
Prevention of chemotherapy-induced nausea and vomiting in the real-world setting in Spain
Escobar Alvarez, Y.; de Castro Carpeno, J.; Bell, D.; Drago, A.; Franceschetti, A.
CLINICAL & TRANSLATIONAL ONCOLOGY
1699-048X (2021)
DOI /
10.1007/s12094-021-02623-8
Hybrid
Mentions
4
Twitter
0
Wikipedia
0
News
2
Policy
Article
Final results of the large-scale multinational trial PROFILE 1005: efficacy and safety of crizotinib in previously treated patients with advanced/metastatic ALK-positive non-small-cell lung cancer
Blackhall, Fiona; Camidge, D. Ross; Shaw, Alice T.; Soria, Jean-Charles; Solomon, Benjamin J.; Mok, Tony; Hirsh, Vera; Jaenne, Pasi A.; Shi, Yuankai; Yang, Pan-Chyr; De Pas, Tommaso; Hida, Toyoaki; De Castro Carpeno, Javier; Lanzalone, Silvana; Polli, Anna
ESMO OPEN
(2017)
DOI /
10.1136/esmoopen-2017-000219
Gold DOAJ, Green published
Mentions
7
Twitter
0
Wikipedia
0
News
0
Policy
Article
Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers
Peters, Solange; Stahel, Rolf; Bubendorf, Lukas; Bonomi, Philip; Villegas, Augusto; Kowalski, Dariusz M.; Baik, Christina S.; Isla, Dolores; De Castro Carpeno, Javier; Garrido, Pilar; Rittmeyer, Achim; Tiseo, Marcello; Meyenberg, Christoph; de Haas, Sanne;
CLINICAL CANCER RESEARCH
1078-0432 (2019)
DOI /
10.1158/1078-0432.ccr-18-1590
Bronze
Mentions
7
Twitter
0
Wikipedia
0
News
0
Policy
Review
PD-L1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer in PD-L1 Positive Patients: A Safety Data Network Meta-Analysis
Garcia Campelo, Maria Rosario; Arriola, Edurne; Campos Balea, Begona; Lopez-Brea, Marta; Fuentes-Pradera, Jose; De Castro Carpeno, Javier; Aguado, Carlos; Perez Parente, Diego; de Oro Pulido, Fidel; Ruiz-Gracia, Pedro; Rodriguez-Abreu, Delvys
JOURNAL OF CLINICAL MEDICINE
(2021)
DOI /
10.3390/jcm10194583
Mentions
5
Twitter
0
Wikipedia
0
News
0
Policy
Article
Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
Campos-Balea, Begona; De Castro Carpeno, Javier; Massuti, Bartomeu; Vicente-Baz, David; Perez Parente, Diego; Ruiz-Gracia, Pedro; Crama, Leonardo; Cobo Dols, Manuel
THORACIC CANCER
1759-7706 (2020)
DOI /
10.1111/1759-7714.13681
Gold DOAJ, Green published
Mentions
8
Twitter
0
Wikipedia
0
News
0
Policy
Article
A phase 1, open-label, dose-escalation trial of oral TSR-011 in patients with advanced solid tumours and lymphomas
Lin, Chia-Chi; Arkenau, Hendrik-Tobias; Lu, Sharon; Sachdev, Jasgit; De Castro Carpeno, Javier; Mita, Monica; Dziadziuszko, Rafal; Su, Wu-Chou; Bobilev, Dmitri; Hughes, Lorraine; Chan, Jian; Zhang, Zhi-Yi; Weiss, Glen J.
BRITISH JOURNAL OF CANCER
0007-0920 (2019)
DOI /
10.1038/s41416-019-0503-9
Gold other, Green published
Mentions
1
Twitter
0
Wikipedia
0
News
0
Policy
Article
Effect of ceritinib on the pharmacokinetics of coadministered CYP3A and 2C9 substrates: a phase I, multicenter, drug-drug interaction study in patients with ALK plus advanced tumors
Hurtado, Felipe K.; De Braud, Filippo; De Castro Carpeno, Javier; de Miguel Luken, Maria Jose; Wang, Ding; Scott, Jeffrey; Lau, Yvonne Y.; McCulloch, Tracey; Mau-Sorensen, Morten
CANCER CHEMOTHERAPY AND PHARMACOLOGY
0344-5704 (2021)
DOI /
10.1007/s00280-020-04180-3
Gold other
Mentions
2
Twitter
0
Wikipedia
0
News
0
Policy
Review
Neoadjuvant Chemoimmunotherapy in Patients with Resectable Non-small Cell Lung Cancer
Gutierrez-Sainz, Laura; Cruz-Castellanos, Patricia; Higuera, Oliver; de Castro-Carpeno, Javier
CURRENT TREATMENT OPTIONS IN ONCOLOGY
1527-2729 (2021)
DOI /
10.1007/s11864-021-00885-6
